Thbs1+ extracellular vesicles from irradiated tumors induce cardiac wasting via PERK-eIF2α-Atf4 signaling
10.2991/978-94-6463-728-1 · doi-reference
A review of dose prediction methods for tumor radiation therapy
10.1016/j.metrad.2024.100057 · doi-reference
Integrating multimodal and multiscale data: a new avenue in cancer research
10.1016/j.metrad.2024.100083 · doi-reference
Engineering precision nanoparticles for drug delivery
10.1038/s41573-020-0090-8 · doi-reference
Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment
10.1016/j.jconrel.2019.12.010 · doi-reference
Effective delivery of paclitaxel-loaded ferritin via inverso CendR peptide for enhanced cancer therapy
10.1021/acs.molpharmaceut.2c00616 · doi-reference
Ferritin cage for encapsulation and delivery of bioactive nutrients: from structure, property to applications
10.1080/10408398.2016.1149690 · doi-reference
Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy
10.1021/mp200600t · doi-reference
Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles
10.3109/1061186x.2015.1016437 · doi-reference
Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models
10.1080/10717544.2021.1921078 · doi-reference
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
10.1200/jco.2005.04.937 · doi-reference
Refractory hypocalcaemia induced by denosumab and nab-paclitaxel in a patient with metastatic breast cancer
10.1016/j.aed.2026.02.011 · doi-reference
Overcoming the blood-brain barrier: successes and challenges in developing nanoparticle-mediated drug delivery systems for the treatment of brain tumours
10.2147/ijn.s231479 · doi-reference
Nab-paclitaxel: a revolution in the nano-therapeutic approach to IDH-wildtype glioblastoma
10.5114/fn.2025.152517 · doi-reference
The uniqueness of albumin as a carrier in nanodrug delivery
10.1021/acs.molpharmaceut.1c00046 · doi-reference
Functional exosome-mediated delivery of triptolide endowed with targeting properties as chemotherapy carriers for ovarian carcinoma
10.1166/jbn.2021.3041 · doi-reference
Novel chinese angelica polysaccharide biomimetic nanomedicine to curcumin delivery for hepatocellular carcinoma treatment and immunomodulatory effect
10.1016/j.phymed.2020.153356 · doi-reference
Biomimetic ginsenoside Rb1 and probucol co-assembled nanoparticles for targeted atherosclerosis therapy via inhibition of oxidative stress, inflammation, and lipid deposition
10.1021/acsnano.5c02492 · doi-reference
Inhalable FN-binding liposomes or liposome-exosome hybrid bionic vesicles encapsulated microparticles for enhanced pulmonary fibrosis therapy
10.1016/j.ijpharm.2024.124096 · doi-reference
β-1,3-D-glucan particles-based “nest” protected co-loaded rhein and emodin regulates microbiota and intestinal immunity for ulcerative colitis treatment
10.1016/j.ijbiomac.2023.128818 · doi-reference
Metal-organic frameworks for drug delivery: a design perspective
10.1021/acsami.1c01089 · doi-reference
Unlocking the potential of mesoporous silica nanoparticles: balancing biomedical applications and safety concerns
10.1080/10717544.2026.2624186 · doi-reference
Meniran (Phyllanthus niruri L.) embedded zeolitic imidazolate framework (ZIF-8) nanoparticle for cancer chemotherapy: supported molecular docking analysis
10.1039/d4ra06399f · doi-reference
Antibacterial and antifungal activities of Pterocarya fraxinifolia extract encapsulated in ZIF-8
10.1002/aoc.70315 · doi-reference
Investigation of metal-organic framework-5 (MOF-5) as an antitumor drug oridonin sustained release carrier
10.3390/molecules24183369 · doi-reference
Synthesis of chitosan oligosaccharide-loaded glycyrrhetinic acid functionalized mesoporous silica nanoparticles and in vitro verification of the treatment of APAP-induced liver injury
10.3390/molecules28104147 · doi-reference
Dual-mode antibacterial core-shell gold nanorod@mesoporous-silica/curcumin nanocomplexes for efficient photothermal and photodynamic therapy
10.1016/j.jphotochem.2021.113722 · doi-reference
The sustained-release agent of total flavonoids of Rhizoma drynariae prepared by nano-mesoporous silica can still promote osteogenesis and angiogenesis in vitro
10.1038/s41598-025-88137-7 · doi-reference
Corrigendum to “PEI-PEG-coated mesoporous silica nanoparticles enhance the antitumor activity of tanshinone IIA and serve as a gene transfer vector”
10.1155/ecam/9763501 · doi-reference
Construction and evaluation of paclitaxel Mn-doped dendritic mesoporous silica coated with N-succinyl chitosan
10.1142/s1793292024500516 · doi-reference
Delivery of paclitaxel by carboxymethyl chitosan-functionalized dendritic fibrous nano-silica: fabrication, characterization, controlled release performance and pharmacokinetics
10.1016/j.ijbiomac.2023.128431 · doi-reference
Traditional chinese medicine polysaccharide in nano-drug delivery systems: current progress and future perspectives
10.1016/j.biopha.2024.116330 · doi-reference
Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States
10.1038/s41598-017-06336-3 · doi-reference
Physicochemical properties of polysaccharides from Dendrobium officinale by fractional precipitation and their preliminary antioxidant and anti-HepG2 cells activities in vitro
10.1186/s13065-018-0468-4 · doi-reference
Structure differences of water soluble polysaccharides in Astragalus membranaceus induced by origin and their bioactivity
10.3390/foods10081755 · doi-reference
A nano drug delivery system based on Angelica sinensis polysaccharide for combination of chemotherapy and immunotherapy
10.3390/molecules25133096 · doi-reference
Self-assembled pH-sensitive nanoparticles based on Ganoderma lucidum polysaccharide-methotrexate conjugates for the co-delivery of anti-tumor drugs
10.1021/acsbiomaterials.1c00663 · doi-reference
Astragalus polysaccharide-based nano-platforms loading PTX to boost chemo-immunotherapy for triple-negative breast cancer with intrinsic GLUT-targeting ability and immunoregulatory activity
10.1186/s12951-025-03708-0 · doi-reference
Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date
10.1007/s11095-016-1958-5 · doi-reference
Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval
10.1016/j.addr.2020.09.009 · doi-reference
